Publication Name	World Journal of Clinical Cases
Manuscript ID	70784
Country	China

Received	2021-11-24 10:13
Peer-Review Started	2021-11-24 10:14
To Make the First Decision
Return for Revision	2021-12-09 06:56
Revised	2021-12-26 16:28
Second Decision	2022-02-28 05:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-03-06 21:44
Articles in Press	2022-03-06 21:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-04-02 00:37
Publish the Manuscript Online	2022-04-21 11:35

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Feng Ding, Ru-Yue Chen, Jun Hou, Jing Guo and Tian-Yi Dong
ORCID	Author(s) ORCID Number Feng Ding http://orcid.org/0000-0003-3865-1768 Ru-Yue Chen http://orcid.org/0000-0002-0847-4740 Jun Hou http://orcid.org/0000-0003-2273-1421 Jing Guo http://orcid.org/0000-0002-3234-1876 Tian-Yi Dong http://orcid.org/0000-0002-7394-1704
Funding Agency and Grant Number
Corresponding Author	Tian-Yi Dong, MD, Chief Doctor, Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwuweiqi Road, Jinan 250021, Shandong Province, China. shandongyiyi2021@163.com
Key Words	Neoadjuvant chemotherapy; Triple-negative breast cancer; Clinical effect; Prognosis; Influencing factor
Core Tip	Neoadjuvant chemotherapy for triple-negative breast cancer (TNBC) treatment can achieve good curative effects. Moreover, tumor-node-metastasis stage, differentiation degree, lymph node metastasis, karyopherin A2 and SRY-related HMG box-2 expressions, and treatment plan are prognostic factors of patients with TNBC
Publish Date	2022-04-21 11:35
Citation	Dong TY, Chen RY, Hou J, Guo J, Ding F. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer. World J Clin Cases 2022; 10(12): 3698-3708
URL	https://www.wjgnet.com/2307-8960/full/v10/i12/3698.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i12.3698

Full Article (PDF)	WJCC-10-3698.pdf
Full Article (Word)	WJCC-10-3698.docx
Manuscript File	70784_Auto_Edited.docx
Answering Reviewers	70784-Answering reviewers.pdf
Audio Core Tip	70784-Audio core tip.mp3
Biostatistics Review Certificate	70784-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	70784-Conflict-of-interest statement.pdf
Copyright License Agreement	70784-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	70784-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	70784-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	70784-Language certificate.pdf
Peer-review Report	70784-Peer-review(s).pdf
Scientific Editor Work List	70784-Scientific editor work list.pdf